NCT04355897View on ClinicalTrials.gov

CoVID-19 Plasma in Treatment of COVID-19 Patients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 28, 2020

Primary Completion Date

July 6, 2020

Study Completion Date

August 12, 2020

Conditions
COVID 19
Interventions
BIOLOGICAL

Convalescent COVID 19 Plasma

Subjects will be transfused intravenously with 500 mls of convalescent COVID 19 plasma

Trial Locations (2)

44106

University Hospitals Cleveland Medical Center, Cleveland

45219

The Christ Hospital, Cincinnati

All Listed Sponsors
lead

The Christ Hospital

OTHER

NCT04355897 - CoVID-19 Plasma in Treatment of COVID-19 Patients | Biotech Hunter | Biotech Hunter